Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 508

1.

Sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with operable breast cancer and positive axillary nodes at initial diagnosis.

Rebollo-Aguirre AC, Gallego-Peinado M, Sánchez-Sánchez R, Pastor-Pons E, García-García J, Chamorro-Santos CE, Menjón-Beltrán S.

Rev Esp Med Nucl Imagen Mol. 2013 Jul-Aug;32(4):240-5. doi: 10.1016/j.remn.2013.03.006. Epub 2013 May 17.

2.

Sentinel lymph node biopsy in patients with operable breast cancer treated with neoadjuvant chemotherapy.

Rebollo-Aguirre AC, Gallego-Peinado M, Menjón-Beltrán S, García-García J, Pastor-Pons E, Chamorro-Santos CE, Ramos-Font C, Salamanca-Ballesteros A, Llamas-Elvira JM, Olea-Serrano N.

Rev Esp Med Nucl Imagen Mol. 2012 May-Jun;31(3):117-23. doi: 10.1016/j.remn.2011.04.007. Epub 2011 Jun 14. English, Spanish.

3.

Sentinel lymph node biopsy in breast cancer patients after neoadjuvant chemotherapy.

Reitsamer R, Peintinger F, Rettenbacher L, Prokop E.

J Surg Oncol. 2003 Oct;84(2):63-7.

PMID:
14502778
4.

Sentinel lymph node biopsy after neoadjuvant chemotherapy is accurate in breast cancer patients with a clinically negative axillary nodal status at presentation.

Gimbergues P, Abrial C, Durando X, Le Bouedec G, Cachin F, Penault-Llorca F, Mouret-Reynier MA, Kwiatkowski F, Maublant J, Tchirkov A, Dauplat J.

Ann Surg Oncol. 2008 May;15(5):1316-21. doi: 10.1245/s10434-007-9759-z. Epub 2008 Mar 1.

PMID:
18311507
5.

Intraoperative sentinel node biopsy by one-step nucleic acid amplification (OSNA) avoids axillary lymphadenectomy in women with breast cancer treated with neoadjuvant chemotherapy.

Navarro-Cecilia J, Dueñas-Rodríguez B, Luque-López C, Ramírez-Expósito MJ, Martínez-Ferrol J, Ruíz-Mateas A, Ureña C, Carrera-González MP, Mayas MD, Martínez-Martos JM.

Eur J Surg Oncol. 2013 Aug;39(8):873-9. doi: 10.1016/j.ejso.2013.05.002. Epub 2013 May 25.

PMID:
23711734
6.

Identification and evaluation of axillary sentinel lymph nodes in patients with breast carcinoma treated with neoadjuvant chemotherapy.

Cohen LF, Breslin TM, Kuerer HM, Ross MI, Hunt KK, Sahin AA.

Am J Surg Pathol. 2000 Sep;24(9):1266-72.

PMID:
10976701
7.

Clinicopathologic analysis of sentinel lymph node mapping in early breast cancer.

Choi SH, Barsky SH, Chang HR.

Breast J. 2003 May-Jun;9(3):153-62.

PMID:
12752622
8.

Sentinel lymph node biopsy examination for breast cancer patients with clinically negative axillary lymph nodes after neoadjuvant chemotherapy.

Kinoshita T, Takasugi M, Iwamoto E, Akashi-Tanaka S, Fukutomi T, Terui S.

Am J Surg. 2006 Feb;191(2):225-9.

PMID:
16442950
9.

Axillary sentinel node biopsy after neoadjuvant chemotherapy.

Ozmen V, Unal ES, Muslumanoglu ME, Igci A, Canbay E, Ozcinar B, Mudun A, Tunaci M, Tuzlali S, Kecer M.

Eur J Surg Oncol. 2010 Jan;36(1):23-9. doi: 10.1016/j.ejso.2009.10.015.

PMID:
19931375
10.

Feasibility and accuracy of sentinel lymph node biopsy after preoperative chemotherapy in breast cancer patients with documented axillary metastases.

Shen J, Gilcrease MZ, Babiera GV, Ross MI, Meric-Bernstam F, Feig BW, Kuerer HM, Francis A, Ames FC, Hunt KK.

Cancer. 2007 Apr 1;109(7):1255-63.

11.

Sentinel lymph node biopsy using periareolar injection of radiocolloid for patients with neoadjuvant chemotherapy-treated breast carcinoma.

Shimazu K, Tamaki Y, Taguchi T, Akazawa K, Inoue T, Noguchi S.

Cancer. 2004 Jun 15;100(12):2555-61.

12.

200 Sentinel lymph node biopsies without axillary lymph node dissection -- no axillary recurrences after a 3-year follow-up.

Reitsamer R, Peintinger F, Prokop E, Rettenbacher L, Menzel C.

Br J Cancer. 2004 Apr 19;90(8):1551-4.

13.

Sentinel node biopsy after neoadjuvant chemotherapy in cytologically proven node-positive breast cancer.

Yagata H, Yamauchi H, Tsugawa K, Hayashi N, Yoshida A, Kajiura Y, In R, Matsuda N, Nakamura S.

Clin Breast Cancer. 2013 Dec;13(6):471-7. doi: 10.1016/j.clbc.2013.08.014.

PMID:
24267732
14.

Sentinel lymph node biopsy alone without axillary lymph node dissection--follow up of sentinel lymph node negative breast cancer patients.

Reitsamer R, Peintinger F, Prokop E, Menzel C, Cimpoca W, Rettenbacher L.

Eur J Surg Oncol. 2003 Apr;29(3):221-3.

PMID:
12657230
15.

Sentinel lymph node biopsy is a reliable method for lymph node evaluation in neoadjuvant chemotherapy-treated patients with breast cancer.

Koslow SB, Eisenberg RE, Qiu Q, Chen Z, Swistel A, Shin SJ.

Am Surg. 2014 Feb;80(2):171-7.

PMID:
24480218
16.

Predictors of non-sentinel lymph node metastasis in breast cancer patients with positive sentinel lymph node (Pilot study).

Eldweny H, Alkhaldy K, Alsaleh N, Abdulsamad M, Abbas A, Hamad A, Mounib S, Essam T, Kukawski P, Bobin JY, Oteifa M, Amanguono H, Abulhoda F, Usmani S, Elbasmy A.

J Egypt Natl Canc Inst. 2012 Mar;24(1):23-30. doi: 10.1016/j.jnci.2011.12.004. Epub 2012 Jan 23.

17.

Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial.

Boughey JC, Suman VJ, Mittendorf EA, Ahrendt GM, Wilke LG, Taback B, Leitch AM, Kuerer HM, Bowling M, Flippo-Morton TS, Byrd DR, Ollila DW, Julian TB, McLaughlin SA, McCall L, Symmans WF, Le-Petross HT, Haffty BG, Buchholz TA, Nelson H, Hunt KK; Alliance for Clinical Trials in Oncology.

JAMA. 2013 Oct 9;310(14):1455-61. doi: 10.1001/jama.2013.278932.

19.

Axillary sentinel lymph node biopsy after neoadjuvant chemotherapy for carcinoma of the breast.

Schwartz GF, Tannebaum JE, Jernigan AM, Palazzo JP.

Cancer. 2010 Mar 1;116(5):1243-51. doi: 10.1002/cncr.24887.

20.

Intraoperative assessment of sentinel lymph node by one-step nucleic acid amplification in breast cancer patients after neoadjuvant treatment reduces the need for a second surgery for axillary lymph node dissection.

Espinosa-Bravo M, Navarro-Cecilia J, Ramos Boyero M, Diaz-Botero S, Dueñas Rodríguez B, Luque López C, Ramos Grande T, Ruano Perez R, Peg V, Rubio IT.

Breast. 2017 Feb;31:40-45. doi: 10.1016/j.breast.2016.10.002. Epub 2016 Nov 2.

PMID:
27810698

Supplemental Content

Support Center